People · Operator
Named in public records as an officer, director or promoter · active 2009–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cerapedics Inc | — | Biotechnology | Series B | $99.1M | $492.3M | 2015 |
| Palyon Medical Corp | — | Biotechnology | Series B | $45.0M | $952.5M | 2009 |
| Cambridge Endoscopic Devices Inc | — | Biotechnology | Seed | $12.0M | $129.8M | 2012 |
Glen Kashuba at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Glen Kashuba on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jonathan Silverstein | 1 | 10 |
| Michael Liang | 1 | 9 |
| Chau Khuong | 1 | 9 |
| Tyrell Rivers | 1 | 6 |
| Noah Kroloff | 1 | 6 |
| Walter Winshall | 1 | 6 |
| Daniel Omstead | 1 | 4 |
| Jeff Barnes | 1 | 4 |
| Chen Schor | 1 | 4 |
| Cherine Plumaker | 1 | 3 |
| James Lousararian | 1 | 3 |
| David Present | 1 | 3 |
| Aidan King | 1 | 3 |
| Antony Koblish | 1 | 3 |
| John Schulte | 1 | 3 |
| HOWARD DONNELLY | 1 | 2 |
| Ken Abramowitz | 1 | 2 |
| Omar Amirana | 1 | 2 |
| Paul J. Mraz | 1 | 1 |
| Leonard J. Habas | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.